Terms of Use
SFA Therapeutics, Inc.
Effective date: 25/04/2022, Last updated: 25/04/2022
1. Acceptance of Terms
These Terms of Use ("Terms") govern your access to and use of the website located at https://sfatherapeutics.com (the "Site"), which is owned and operated by SFA Therapeutics, Inc., a Delaware corporation ("SFA Therapeutics," "Company," "we," "us," or "our").
By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy and Cookie Policy, which are incorporated herein by reference. If you do not agree to these Terms, you must not access or use the Site.
2. About the Site
SFA Therapeutics is a clinical-stage biopharmaceutical company developing deuterated short-chain fatty acid therapeutics. The Site provides general information about the Company, its pipeline of investigational therapies, clinical trial activities, leadership team, and investor relations.
The Site is intended for informational purposes only and is directed primarily at investors, healthcare professionals, and the general public.
3. Investigational Therapy Disclaimer
SFA-002 and all other SFA Therapeutics pipeline candidates referenced on the Site are investigational therapies. They have not been approved by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority. The safety and efficacy of these therapies have not been established.
The clinical data, study results, and scientific information presented on the Site are provided for informational purposes only and should not be interpreted as a guarantee or prediction of future results. Individual outcomes may vary. Phase 1b results described on the Site are from an open-label study and have not been confirmed in a randomized, placebo-controlled trial.
4. No Medical Advice
Nothing on the Site constitutes or is intended to constitute medical advice, diagnosis, or treatment. The information on the Site should not be used as a substitute for professional medical advice from a qualified healthcare provider. You should not rely on any information on the Site to make decisions about your health or medical treatment.
If you are a patient seeking information about clinical trial participation, please consult your physician and visit ClinicalTrials.gov for official trial information.
5. No Investment Advice or Offer of Securities
The information on the Site does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any securities. Nothing on the Site should be construed as investment advice, financial advice, or a recommendation to invest in SFA Therapeutics or any associated entity.
Any investment decisions should be made solely on the basis of your own due diligence and consultation with your financial, legal, and tax advisors. Past performance and clinical results described on the Site are not indicative of future results.
6. Forward-Looking Statements
The Site may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. These statements relate to future events or future financial or operational performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by any forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding:
- The development, timing, and results of clinical trials for SFA-002 and other pipeline candidates.
- Expectations regarding regulatory submissions and approvals.
- The potential therapeutic benefits of the Company's investigational products.
- The Company's business strategy, plans, and objectives.
These forward-looking statements are based on current expectations and assumptions as of the date they are made. SFA Therapeutics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
7. Information We Collect
7.1 Ownership
All content on the Site, including but not limited to text, graphics, images, logos, trademarks, trade names, data compilations, clinical photography, scientific data, page layout, and underlying code (collectively, "Content"), is the property of SFA Therapeutics or its licensors and is protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property and proprietary rights laws.
"SFA Therapeutics," "SFA-002," "SFA-001," "SFA-009," and related names, logos, and designs are trademarks or service marks of SFA Therapeutics, Inc. You may not use any of these marks without our prior written consent.
7.2 Limited License
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for your personal, non-commercial, informational purposes. This license does not include the right to:
- Modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any Content.
- Use any data mining, robots, or similar data gathering or extraction methods on the Site.
- Use the Site or Content for any commercial purpose without our prior written consent.
- Frame or mirror any portion of the Site without our prior written authorization.
7.3 Clinical Photography
Clinical photographs displayed on the Site are published with patient consent and are the exclusive property of SFA Therapeutics. Reproduction, distribution, or use of clinical photography without the express written permission of SFA Therapeutics is strictly prohibited.
8. User Conduct
By using the Site, you agree that you will not:
- Use the Site in any manner that could disable, overburden, damage, or impair the Site or interfere with any other party's use of the Site.
- Use any automated means, including robots, crawlers, or scrapers, to access the Site for any purpose without our express written permission.
- Attempt to gain unauthorized access to any portion of the Site, other accounts, computer systems, or networks connected to the Site.
- Use the Site for any purpose that is unlawful, fraudulent, or prohibited by these Terms.
- Introduce any viruses, trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
- Collect or harvest any personally identifiable information from the Site.
- Impersonate or attempt to impersonate the Company, a Company employee, another user, or any other person or entity.t
9. Third-Party Links
The Site may contain links to third-party websites or resources, including but not limited to ClinicalTrials.gov. These links are provided for convenience only and do not constitute an endorsement, sponsorship, or recommendation by SFA Therapeutics. We have no control over, and assume no responsibility for, the content, privacy policies, or practices of any third-party websites. You access third-party websites at your own risk.
10. Disclaimer of Warranties
THE SITE AND ALL CONTENT ARE PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SFA THERAPEUTICS DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:
- IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
- WARRANTIES THAT THE SITE WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.
- WARRANTIES REGARDING THE ACCURACY, COMPLETENESS, RELIABILITY, TIMELINESS, OR SUITABILITY OF ANY CONTENT ON THE SITE.
SFA THERAPEUTICS DOES NOT WARRANT THAT THE RESULTS OF CLINICAL TRIALS OR INVESTIGATIONAL THERAPIES DESCRIBED ON THE SITE WILL BE REPLICATED IN FUTURE STUDIES OR THAT ANY INVESTIGATIONAL THERAPY WILL RECEIVE REGULATORY APPROVAL.
11. Limitation of Liability
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL SFA THERAPEUTICS, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATED TO:
- YOUR ACCESS TO, USE OF, OR INABILITY TO ACCESS OR USE THE SITE.
- ANY CONTENT OR INFORMATION OBTAINED FROM THE SITE.
- ANY CONDUCT OR CONTENT OF ANY THIRD PARTY ON OR CONNECTED TO THE SITE.
- UNAUTHORIZED ACCESS, USE, OR ALTERATION OF YOUR TRANSMISSIONS OR DATA.
- ANY RELIANCE ON CLINICAL DATA, STUDY RESULTS, OR SCIENTIFIC INFORMATION PRESENTED ON THE SITE.
THIS LIMITATION APPLIES WHETHER THE CLAIM IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, EVEN IF SFA THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OUR LIABILITY SHALL BE LIMITED TO THE MAXIMUM EXTENT PERMITTED BY LAW.
12. Indemnification
You agree to indemnify, defend, and hold harmless SFA Therapeutics, its officers, directors, employees, agents, affiliates, and licensors from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) your use of the Site; (b) your violation of these Terms; or (c) your violation of any rights of a third party.
13. Governing Law and Dispute Resolution
13.1 Governing Law
These Terms and any disputes arising out of or relating to these Terms or the Site shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law principles.
13.2 Jurisdiction
You agree that any legal action or proceeding arising out of or relating to these Terms or the Site shall be brought exclusively in the federal or state courts located in the State of Delaware, and you hereby consent to the personal jurisdiction and venue of such courts.
13.3 Waiver of Jury Trial
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE ARISING OUT OF OR RELATING TO THESE TERMS OR THE SITE.
14. Modifications to These Terms
SFA Therapeutics reserves the right to modify or replace these Terms at any time in its sole discretion. When we make material changes, we will update the "Last Updated" date at the top of this page. Your continued use of the Site after the posting of revised Terms constitutes your acceptance of such changes.
We encourage you to review these Terms periodically.
15. Modifications to the Site
SFA Therapeutics reserves the right to modify, suspend, or discontinue the Site, or any portion thereof, at any time without notice or liability. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Site.
16. Severability
If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such invalidity, illegality, or unenforceability shall not affect the remaining provisions of these Terms, which shall remain in full force and effect.
17. Waiver
The failure of SFA Therapeutics to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. Any waiver of any provision of these Terms will be effective only if in writing and signed by SFA Therapeutics.
18. Entire Agreement
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and SFA Therapeutics regarding your use of the Site and supersede all prior and contemporaneous agreements, communications, and proposals, whether oral or written, between you and SFA Therapeutics regarding the Site.
19. Contact Us
If you have any questions about these Terms, please contact us at:
James Kirwin, Data Protection Officer SFA Therapeutics, Inc. 610 Old York Road, Suite 400, Jenkintown, PA 19046 Email: jameskirwin@sfatherapeutics.com
© 2026 SFA Therapeutics, Inc. All rights reserved.
Resetting the immune system © 2026 SFA Therapeutics, Inc.
SFA-002 and all SFA Therapeutics pipeline candidates are investigational therapies and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these therapies have not been established. The information on this website is intended for informational purposes only and should not be construed as medical advice or an offer to participate in a clinical trial. ClinicalTrials.gov Identifier: [pending registration].
Terms of Use
SFA Therapeutics, Inc.
Effective date: 25/04/2022, Last updated: 25/04/2022
1. Acceptance of Terms
These Terms of Use ("Terms") govern your access to and use of the website located at https://sfatherapeutics.com (the "Site"), which is owned and operated by SFA Therapeutics, Inc., a Delaware corporation ("SFA Therapeutics," "Company," "we," "us," or "our").
By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy and Cookie Policy, which are incorporated herein by reference. If you do not agree to these Terms, you must not access or use the Site.
2. About the Site
SFA Therapeutics is a clinical-stage biopharmaceutical company developing deuterated short-chain fatty acid therapeutics. The Site provides general information about the Company, its pipeline of investigational therapies, clinical trial activities, leadership team, and investor relations.
The Site is intended for informational purposes only and is directed primarily at investors, healthcare professionals, and the general public.
3. Investigational Therapy Disclaimer
SFA-002 and all other SFA Therapeutics pipeline candidates referenced on the Site are investigational therapies. They have not been approved by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority. The safety and efficacy of these therapies have not been established.
The clinical data, study results, and scientific information presented on the Site are provided for informational purposes only and should not be interpreted as a guarantee or prediction of future results. Individual outcomes may vary. Phase 1b results described on the Site are from an open-label study and have not been confirmed in a randomized, placebo-controlled trial.
4. No Medical Advice
Nothing on the Site constitutes or is intended to constitute medical advice, diagnosis, or treatment. The information on the Site should not be used as a substitute for professional medical advice from a qualified healthcare provider. You should not rely on any information on the Site to make decisions about your health or medical treatment.
If you are a patient seeking information about clinical trial participation, please consult your physician and visit ClinicalTrials.gov for official trial information.
5. No Investment Advice or Offer of Securities
The information on the Site does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any securities. Nothing on the Site should be construed as investment advice, financial advice, or a recommendation to invest in SFA Therapeutics or any associated entity.
Any investment decisions should be made solely on the basis of your own due diligence and consultation with your financial, legal, and tax advisors. Past performance and clinical results described on the Site are not indicative of future results.
6. Forward-Looking Statements
The Site may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. These statements relate to future events or future financial or operational performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by any forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding:
- The development, timing, and results of clinical trials for SFA-002 and other pipeline candidates.
- Expectations regarding regulatory submissions and approvals.
- The potential therapeutic benefits of the Company's investigational products.
- The Company's business strategy, plans, and objectives.
These forward-looking statements are based on current expectations and assumptions as of the date they are made. SFA Therapeutics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
7. Information We Collect
7.1 Ownership
All content on the Site, including but not limited to text, graphics, images, logos, trademarks, trade names, data compilations, clinical photography, scientific data, page layout, and underlying code (collectively, "Content"), is the property of SFA Therapeutics or its licensors and is protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property and proprietary rights laws.
"SFA Therapeutics," "SFA-002," "SFA-001," "SFA-009," and related names, logos, and designs are trademarks or service marks of SFA Therapeutics, Inc. You may not use any of these marks without our prior written consent.
7.2 Limited License
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for your personal, non-commercial, informational purposes. This license does not include the right to:
- Modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any Content.
- Use any data mining, robots, or similar data gathering or extraction methods on the Site.
- Use the Site or Content for any commercial purpose without our prior written consent.
- Frame or mirror any portion of the Site without our prior written authorization.
7.3 Clinical Photography
Clinical photographs displayed on the Site are published with patient consent and are the exclusive property of SFA Therapeutics. Reproduction, distribution, or use of clinical photography without the express written permission of SFA Therapeutics is strictly prohibited.
8. User Conduct
By using the Site, you agree that you will not:
- Use the Site in any manner that could disable, overburden, damage, or impair the Site or interfere with any other party's use of the Site.
- Use any automated means, including robots, crawlers, or scrapers, to access the Site for any purpose without our express written permission.
- Attempt to gain unauthorized access to any portion of the Site, other accounts, computer systems, or networks connected to the Site.
- Use the Site for any purpose that is unlawful, fraudulent, or prohibited by these Terms.
- Introduce any viruses, trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
- Collect or harvest any personally identifiable information from the Site.
- Impersonate or attempt to impersonate the Company, a Company employee, another user, or any other person or entity.t
9. Third-Party Links
The Site may contain links to third-party websites or resources, including but not limited to ClinicalTrials.gov. These links are provided for convenience only and do not constitute an endorsement, sponsorship, or recommendation by SFA Therapeutics. We have no control over, and assume no responsibility for, the content, privacy policies, or practices of any third-party websites. You access third-party websites at your own risk.
10. Disclaimer of Warranties
THE SITE AND ALL CONTENT ARE PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SFA THERAPEUTICS DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:
- IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
- WARRANTIES THAT THE SITE WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.
- WARRANTIES REGARDING THE ACCURACY, COMPLETENESS, RELIABILITY, TIMELINESS, OR SUITABILITY OF ANY CONTENT ON THE SITE.
SFA THERAPEUTICS DOES NOT WARRANT THAT THE RESULTS OF CLINICAL TRIALS OR INVESTIGATIONAL THERAPIES DESCRIBED ON THE SITE WILL BE REPLICATED IN FUTURE STUDIES OR THAT ANY INVESTIGATIONAL THERAPY WILL RECEIVE REGULATORY APPROVAL.
11. Limitation of Liability
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL SFA THERAPEUTICS, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATED TO:
- YOUR ACCESS TO, USE OF, OR INABILITY TO ACCESS OR USE THE SITE.
- ANY CONTENT OR INFORMATION OBTAINED FROM THE SITE.
- ANY CONDUCT OR CONTENT OF ANY THIRD PARTY ON OR CONNECTED TO THE SITE.
- UNAUTHORIZED ACCESS, USE, OR ALTERATION OF YOUR TRANSMISSIONS OR DATA.
- ANY RELIANCE ON CLINICAL DATA, STUDY RESULTS, OR SCIENTIFIC INFORMATION PRESENTED ON THE SITE.
THIS LIMITATION APPLIES WHETHER THE CLAIM IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, EVEN IF SFA THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OUR LIABILITY SHALL BE LIMITED TO THE MAXIMUM EXTENT PERMITTED BY LAW.
12. Indemnification
You agree to indemnify, defend, and hold harmless SFA Therapeutics, its officers, directors, employees, agents, affiliates, and licensors from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) your use of the Site; (b) your violation of these Terms; or (c) your violation of any rights of a third party.
13. Governing Law and Dispute Resolution
13.1 Governing Law
These Terms and any disputes arising out of or relating to these Terms or the Site shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law principles.
13.2 Jurisdiction
You agree that any legal action or proceeding arising out of or relating to these Terms or the Site shall be brought exclusively in the federal or state courts located in the State of Delaware, and you hereby consent to the personal jurisdiction and venue of such courts.
13.3 Waiver of Jury Trial
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE ARISING OUT OF OR RELATING TO THESE TERMS OR THE SITE.
14. Modifications to These Terms
SFA Therapeutics reserves the right to modify or replace these Terms at any time in its sole discretion. When we make material changes, we will update the "Last Updated" date at the top of this page. Your continued use of the Site after the posting of revised Terms constitutes your acceptance of such changes.
We encourage you to review these Terms periodically.
15. Modifications to the Site
SFA Therapeutics reserves the right to modify, suspend, or discontinue the Site, or any portion thereof, at any time without notice or liability. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Site.
16. Severability
If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such invalidity, illegality, or unenforceability shall not affect the remaining provisions of these Terms, which shall remain in full force and effect.
17. Waiver
The failure of SFA Therapeutics to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. Any waiver of any provision of these Terms will be effective only if in writing and signed by SFA Therapeutics.
18. Entire Agreement
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and SFA Therapeutics regarding your use of the Site and supersede all prior and contemporaneous agreements, communications, and proposals, whether oral or written, between you and SFA Therapeutics regarding the Site.
19. Contact Us
If you have any questions about these Terms, please contact us at:
James Kirwin, Data Protection Officer SFA Therapeutics, Inc. 610 Old York Road, Suite 400, Jenkintown, PA 19046 Email: jameskirwin@sfatherapeutics.com
© 2026 SFA Therapeutics, Inc. All rights reserved.
Resetting the immune system © 2026 SFA Therapeutics, Inc.
SFA-002 and all SFA Therapeutics pipeline candidates are investigational therapies and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these therapies have not been established. The information on this website is intended for informational purposes only and should not be construed as medical advice or an offer to participate in a clinical trial. ClinicalTrials.gov Identifier: [pending registration].
Terms of Use
SFA Therapeutics, Inc.
Effective date: 25/04/2022, Last updated: 25/04/2022
1. Acceptance of Terms
These Terms of Use ("Terms") govern your access to and use of the website located at https://sfatherapeutics.com (the "Site"), which is owned and operated by SFA Therapeutics, Inc., a Delaware corporation ("SFA Therapeutics," "Company," "we," "us," or "our").
By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy and Cookie Policy, which are incorporated herein by reference. If you do not agree to these Terms, you must not access or use the Site.
2. About the Site
SFA Therapeutics is a clinical-stage biopharmaceutical company developing deuterated short-chain fatty acid therapeutics. The Site provides general information about the Company, its pipeline of investigational therapies, clinical trial activities, leadership team, and investor relations.
The Site is intended for informational purposes only and is directed primarily at investors, healthcare professionals, and the general public.
3. Investigational Therapy Disclaimer
SFA-002 and all other SFA Therapeutics pipeline candidates referenced on the Site are investigational therapies. They have not been approved by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority. The safety and efficacy of these therapies have not been established.
The clinical data, study results, and scientific information presented on the Site are provided for informational purposes only and should not be interpreted as a guarantee or prediction of future results. Individual outcomes may vary. Phase 1b results described on the Site are from an open-label study and have not been confirmed in a randomized, placebo-controlled trial.
4. No Medical Advice
Nothing on the Site constitutes or is intended to constitute medical advice, diagnosis, or treatment. The information on the Site should not be used as a substitute for professional medical advice from a qualified healthcare provider. You should not rely on any information on the Site to make decisions about your health or medical treatment.
If you are a patient seeking information about clinical trial participation, please consult your physician and visit ClinicalTrials.gov for official trial information.
5. No Investment Advice or Offer of Securities
The information on the Site does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any securities. Nothing on the Site should be construed as investment advice, financial advice, or a recommendation to invest in SFA Therapeutics or any associated entity.
Any investment decisions should be made solely on the basis of your own due diligence and consultation with your financial, legal, and tax advisors. Past performance and clinical results described on the Site are not indicative of future results.
6. Forward-Looking Statements
The Site may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. These statements relate to future events or future financial or operational performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by any forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding:
- The development, timing, and results of clinical trials for SFA-002 and other pipeline candidates.
- Expectations regarding regulatory submissions and approvals.
- The potential therapeutic benefits of the Company's investigational products.
- The Company's business strategy, plans, and objectives.
These forward-looking statements are based on current expectations and assumptions as of the date they are made. SFA Therapeutics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
7. Information We Collect
7.1 Ownership
All content on the Site, including but not limited to text, graphics, images, logos, trademarks, trade names, data compilations, clinical photography, scientific data, page layout, and underlying code (collectively, "Content"), is the property of SFA Therapeutics or its licensors and is protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property and proprietary rights laws.
"SFA Therapeutics," "SFA-002," "SFA-001," "SFA-009," and related names, logos, and designs are trademarks or service marks of SFA Therapeutics, Inc. You may not use any of these marks without our prior written consent.
7.2 Limited License
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for your personal, non-commercial, informational purposes. This license does not include the right to:
- Modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any Content.
- Use any data mining, robots, or similar data gathering or extraction methods on the Site.
- Use the Site or Content for any commercial purpose without our prior written consent.
- Frame or mirror any portion of the Site without our prior written authorization.
7.3 Clinical Photography
Clinical photographs displayed on the Site are published with patient consent and are the exclusive property of SFA Therapeutics. Reproduction, distribution, or use of clinical photography without the express written permission of SFA Therapeutics is strictly prohibited.
8. User Conduct
By using the Site, you agree that you will not:
- Use the Site in any manner that could disable, overburden, damage, or impair the Site or interfere with any other party's use of the Site.
- Use any automated means, including robots, crawlers, or scrapers, to access the Site for any purpose without our express written permission.
- Attempt to gain unauthorized access to any portion of the Site, other accounts, computer systems, or networks connected to the Site.
- Use the Site for any purpose that is unlawful, fraudulent, or prohibited by these Terms.
- Introduce any viruses, trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
- Collect or harvest any personally identifiable information from the Site.
- Impersonate or attempt to impersonate the Company, a Company employee, another user, or any other person or entity.t
9. Third-Party Links
The Site may contain links to third-party websites or resources, including but not limited to ClinicalTrials.gov. These links are provided for convenience only and do not constitute an endorsement, sponsorship, or recommendation by SFA Therapeutics. We have no control over, and assume no responsibility for, the content, privacy policies, or practices of any third-party websites. You access third-party websites at your own risk.
10. Disclaimer of Warranties
THE SITE AND ALL CONTENT ARE PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SFA THERAPEUTICS DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:
- IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
- WARRANTIES THAT THE SITE WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.
- WARRANTIES REGARDING THE ACCURACY, COMPLETENESS, RELIABILITY, TIMELINESS, OR SUITABILITY OF ANY CONTENT ON THE SITE.
SFA THERAPEUTICS DOES NOT WARRANT THAT THE RESULTS OF CLINICAL TRIALS OR INVESTIGATIONAL THERAPIES DESCRIBED ON THE SITE WILL BE REPLICATED IN FUTURE STUDIES OR THAT ANY INVESTIGATIONAL THERAPY WILL RECEIVE REGULATORY APPROVAL.
11. Limitation of Liability
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL SFA THERAPEUTICS, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATED TO:
- YOUR ACCESS TO, USE OF, OR INABILITY TO ACCESS OR USE THE SITE.
- ANY CONTENT OR INFORMATION OBTAINED FROM THE SITE.
- ANY CONDUCT OR CONTENT OF ANY THIRD PARTY ON OR CONNECTED TO THE SITE.
- UNAUTHORIZED ACCESS, USE, OR ALTERATION OF YOUR TRANSMISSIONS OR DATA.
- ANY RELIANCE ON CLINICAL DATA, STUDY RESULTS, OR SCIENTIFIC INFORMATION PRESENTED ON THE SITE.
THIS LIMITATION APPLIES WHETHER THE CLAIM IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, EVEN IF SFA THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OUR LIABILITY SHALL BE LIMITED TO THE MAXIMUM EXTENT PERMITTED BY LAW.
12. Indemnification
You agree to indemnify, defend, and hold harmless SFA Therapeutics, its officers, directors, employees, agents, affiliates, and licensors from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) your use of the Site; (b) your violation of these Terms; or (c) your violation of any rights of a third party.
13. Governing Law and Dispute Resolution
13.1 Governing Law
These Terms and any disputes arising out of or relating to these Terms or the Site shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law principles.
13.2 Jurisdiction
You agree that any legal action or proceeding arising out of or relating to these Terms or the Site shall be brought exclusively in the federal or state courts located in the State of Delaware, and you hereby consent to the personal jurisdiction and venue of such courts.
13.3 Waiver of Jury Trial
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE ARISING OUT OF OR RELATING TO THESE TERMS OR THE SITE.
14. Modifications to These Terms
SFA Therapeutics reserves the right to modify or replace these Terms at any time in its sole discretion. When we make material changes, we will update the "Last Updated" date at the top of this page. Your continued use of the Site after the posting of revised Terms constitutes your acceptance of such changes.
We encourage you to review these Terms periodically.
15. Modifications to the Site
SFA Therapeutics reserves the right to modify, suspend, or discontinue the Site, or any portion thereof, at any time without notice or liability. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Site.
16. Severability
If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such invalidity, illegality, or unenforceability shall not affect the remaining provisions of these Terms, which shall remain in full force and effect.
17. Waiver
The failure of SFA Therapeutics to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. Any waiver of any provision of these Terms will be effective only if in writing and signed by SFA Therapeutics.
18. Entire Agreement
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and SFA Therapeutics regarding your use of the Site and supersede all prior and contemporaneous agreements, communications, and proposals, whether oral or written, between you and SFA Therapeutics regarding the Site.
19. Contact Us
If you have any questions about these Terms, please contact us at:
James Kirwin, Data Protection Officer SFA Therapeutics, Inc. 610 Old York Road, Suite 400, Jenkintown, PA 19046 Email: jameskirwin@sfatherapeutics.com
© 2026 SFA Therapeutics, Inc. All rights reserved.
Resetting the immune system © 2026 SFA Therapeutics, Inc.
SFA-002 and all SFA Therapeutics pipeline candidates are investigational therapies and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these therapies have not been established. The information on this website is intended for informational purposes only and should not be construed as medical advice or an offer to participate in a clinical trial. ClinicalTrials.gov Identifier: [pending registration].
Terms of Use
SFA Therapeutics, Inc.
Effective date: 25/04/2022, Last updated: 25/04/2022
1. Acceptance of Terms
These Terms of Use ("Terms") govern your access to and use of the website located at https://sfatherapeutics.com (the "Site"), which is owned and operated by SFA Therapeutics, Inc., a Delaware corporation ("SFA Therapeutics," "Company," "we," "us," or "our").
By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy and Cookie Policy, which are incorporated herein by reference. If you do not agree to these Terms, you must not access or use the Site.
2. About the Site
SFA Therapeutics is a clinical-stage biopharmaceutical company developing deuterated short-chain fatty acid therapeutics. The Site provides general information about the Company, its pipeline of investigational therapies, clinical trial activities, leadership team, and investor relations.
The Site is intended for informational purposes only and is directed primarily at investors, healthcare professionals, and the general public.
3. Investigational Therapy Disclaimer
SFA-002 and all other SFA Therapeutics pipeline candidates referenced on the Site are investigational therapies. They have not been approved by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority. The safety and efficacy of these therapies have not been established.
The clinical data, study results, and scientific information presented on the Site are provided for informational purposes only and should not be interpreted as a guarantee or prediction of future results. Individual outcomes may vary. Phase 1b results described on the Site are from an open-label study and have not been confirmed in a randomized, placebo-controlled trial.
4. No Medical Advice
Nothing on the Site constitutes or is intended to constitute medical advice, diagnosis, or treatment. The information on the Site should not be used as a substitute for professional medical advice from a qualified healthcare provider. You should not rely on any information on the Site to make decisions about your health or medical treatment.
If you are a patient seeking information about clinical trial participation, please consult your physician and visit ClinicalTrials.gov for official trial information.
5. No Investment Advice or Offer of Securities
The information on the Site does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any securities. Nothing on the Site should be construed as investment advice, financial advice, or a recommendation to invest in SFA Therapeutics or any associated entity.
Any investment decisions should be made solely on the basis of your own due diligence and consultation with your financial, legal, and tax advisors. Past performance and clinical results described on the Site are not indicative of future results.
6. Forward-Looking Statements
The Site may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. These statements relate to future events or future financial or operational performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by any forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding:
- The development, timing, and results of clinical trials for SFA-002 and other pipeline candidates.
- Expectations regarding regulatory submissions and approvals.
- The potential therapeutic benefits of the Company's investigational products.
- The Company's business strategy, plans, and objectives.
These forward-looking statements are based on current expectations and assumptions as of the date they are made. SFA Therapeutics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
7. Information We Collect
7.1 Ownership
All content on the Site, including but not limited to text, graphics, images, logos, trademarks, trade names, data compilations, clinical photography, scientific data, page layout, and underlying code (collectively, "Content"), is the property of SFA Therapeutics or its licensors and is protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property and proprietary rights laws.
"SFA Therapeutics," "SFA-002," "SFA-001," "SFA-009," and related names, logos, and designs are trademarks or service marks of SFA Therapeutics, Inc. You may not use any of these marks without our prior written consent.
7.2 Limited License
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for your personal, non-commercial, informational purposes. This license does not include the right to:
- Modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any Content.
- Use any data mining, robots, or similar data gathering or extraction methods on the Site.
- Use the Site or Content for any commercial purpose without our prior written consent.
- Frame or mirror any portion of the Site without our prior written authorization.
7.3 Clinical Photography
Clinical photographs displayed on the Site are published with patient consent and are the exclusive property of SFA Therapeutics. Reproduction, distribution, or use of clinical photography without the express written permission of SFA Therapeutics is strictly prohibited.
8. User Conduct
By using the Site, you agree that you will not:
- Use the Site in any manner that could disable, overburden, damage, or impair the Site or interfere with any other party's use of the Site.
- Use any automated means, including robots, crawlers, or scrapers, to access the Site for any purpose without our express written permission.
- Attempt to gain unauthorized access to any portion of the Site, other accounts, computer systems, or networks connected to the Site.
- Use the Site for any purpose that is unlawful, fraudulent, or prohibited by these Terms.
- Introduce any viruses, trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
- Collect or harvest any personally identifiable information from the Site.
- Impersonate or attempt to impersonate the Company, a Company employee, another user, or any other person or entity.t
9. Third-Party Links
The Site may contain links to third-party websites or resources, including but not limited to ClinicalTrials.gov. These links are provided for convenience only and do not constitute an endorsement, sponsorship, or recommendation by SFA Therapeutics. We have no control over, and assume no responsibility for, the content, privacy policies, or practices of any third-party websites. You access third-party websites at your own risk.
10. Disclaimer of Warranties
THE SITE AND ALL CONTENT ARE PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SFA THERAPEUTICS DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:
- IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
- WARRANTIES THAT THE SITE WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.
- WARRANTIES REGARDING THE ACCURACY, COMPLETENESS, RELIABILITY, TIMELINESS, OR SUITABILITY OF ANY CONTENT ON THE SITE.
SFA THERAPEUTICS DOES NOT WARRANT THAT THE RESULTS OF CLINICAL TRIALS OR INVESTIGATIONAL THERAPIES DESCRIBED ON THE SITE WILL BE REPLICATED IN FUTURE STUDIES OR THAT ANY INVESTIGATIONAL THERAPY WILL RECEIVE REGULATORY APPROVAL.
11. Limitation of Liability
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL SFA THERAPEUTICS, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATED TO:
- YOUR ACCESS TO, USE OF, OR INABILITY TO ACCESS OR USE THE SITE.
- ANY CONTENT OR INFORMATION OBTAINED FROM THE SITE.
- ANY CONDUCT OR CONTENT OF ANY THIRD PARTY ON OR CONNECTED TO THE SITE.
- UNAUTHORIZED ACCESS, USE, OR ALTERATION OF YOUR TRANSMISSIONS OR DATA.
- ANY RELIANCE ON CLINICAL DATA, STUDY RESULTS, OR SCIENTIFIC INFORMATION PRESENTED ON THE SITE.
THIS LIMITATION APPLIES WHETHER THE CLAIM IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, EVEN IF SFA THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OUR LIABILITY SHALL BE LIMITED TO THE MAXIMUM EXTENT PERMITTED BY LAW.
12. Indemnification
You agree to indemnify, defend, and hold harmless SFA Therapeutics, its officers, directors, employees, agents, affiliates, and licensors from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) your use of the Site; (b) your violation of these Terms; or (c) your violation of any rights of a third party.
13. Governing Law and Dispute Resolution
13.1 Governing Law
These Terms and any disputes arising out of or relating to these Terms or the Site shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law principles.
13.2 Jurisdiction
You agree that any legal action or proceeding arising out of or relating to these Terms or the Site shall be brought exclusively in the federal or state courts located in the State of Delaware, and you hereby consent to the personal jurisdiction and venue of such courts.
13.3 Waiver of Jury Trial
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE ARISING OUT OF OR RELATING TO THESE TERMS OR THE SITE.
14. Modifications to These Terms
SFA Therapeutics reserves the right to modify or replace these Terms at any time in its sole discretion. When we make material changes, we will update the "Last Updated" date at the top of this page. Your continued use of the Site after the posting of revised Terms constitutes your acceptance of such changes.
We encourage you to review these Terms periodically.
15. Modifications to the Site
SFA Therapeutics reserves the right to modify, suspend, or discontinue the Site, or any portion thereof, at any time without notice or liability. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Site.
16. Severability
If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such invalidity, illegality, or unenforceability shall not affect the remaining provisions of these Terms, which shall remain in full force and effect.
17. Waiver
The failure of SFA Therapeutics to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. Any waiver of any provision of these Terms will be effective only if in writing and signed by SFA Therapeutics.
18. Entire Agreement
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and SFA Therapeutics regarding your use of the Site and supersede all prior and contemporaneous agreements, communications, and proposals, whether oral or written, between you and SFA Therapeutics regarding the Site.
19. Contact Us
If you have any questions about these Terms, please contact us at:
James Kirwin, Data Protection Officer SFA Therapeutics, Inc. 610 Old York Road, Suite 400, Jenkintown, PA 19046 Email: jameskirwin@sfatherapeutics.com
© 2026 SFA Therapeutics, Inc. All rights reserved.
Resetting the immune system © 2026 SFA Therapeutics, Inc.
SFA-002 and all SFA Therapeutics pipeline candidates are investigational therapies and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these therapies have not been established. The information on this website is intended for informational purposes only and should not be construed as medical advice or an offer to participate in a clinical trial. ClinicalTrials.gov Identifier: [pending registration].
Terms of Use
SFA Therapeutics, Inc.
Effective date: 25/04/2022, Last updated: 25/04/2022
1. Acceptance of Terms
These Terms of Use ("Terms") govern your access to and use of the website located at https://sfatherapeutics.com (the "Site"), which is owned and operated by SFA Therapeutics, Inc., a Delaware corporation ("SFA Therapeutics," "Company," "we," "us," or "our").
By accessing or using the Site, you agree to be bound by these Terms and our Privacy Policy and Cookie Policy, which are incorporated herein by reference. If you do not agree to these Terms, you must not access or use the Site.
2. About the Site
SFA Therapeutics is a clinical-stage biopharmaceutical company developing deuterated short-chain fatty acid therapeutics. The Site provides general information about the Company, its pipeline of investigational therapies, clinical trial activities, leadership team, and investor relations.
The Site is intended for informational purposes only and is directed primarily at investors, healthcare professionals, and the general public.
3. Investigational Therapy Disclaimer
SFA-002 and all other SFA Therapeutics pipeline candidates referenced on the Site are investigational therapies. They have not been approved by the U.S. Food and Drug Administration ("FDA") or any other regulatory authority. The safety and efficacy of these therapies have not been established.
The clinical data, study results, and scientific information presented on the Site are provided for informational purposes only and should not be interpreted as a guarantee or prediction of future results. Individual outcomes may vary. Phase 1b results described on the Site are from an open-label study and have not been confirmed in a randomized, placebo-controlled trial.
4. No Medical Advice
Nothing on the Site constitutes or is intended to constitute medical advice, diagnosis, or treatment. The information on the Site should not be used as a substitute for professional medical advice from a qualified healthcare provider. You should not rely on any information on the Site to make decisions about your health or medical treatment.
If you are a patient seeking information about clinical trial participation, please consult your physician and visit ClinicalTrials.gov for official trial information.
5. No Investment Advice or Offer of Securities
The information on the Site does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any securities. Nothing on the Site should be construed as investment advice, financial advice, or a recommendation to invest in SFA Therapeutics or any associated entity.
Any investment decisions should be made solely on the basis of your own due diligence and consultation with your financial, legal, and tax advisors. Past performance and clinical results described on the Site are not indicative of future results.
6. Forward-Looking Statements
The Site may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. These statements relate to future events or future financial or operational performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by any forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding:
- The development, timing, and results of clinical trials for SFA-002 and other pipeline candidates.
- Expectations regarding regulatory submissions and approvals.
- The potential therapeutic benefits of the Company's investigational products.
- The Company's business strategy, plans, and objectives.
These forward-looking statements are based on current expectations and assumptions as of the date they are made. SFA Therapeutics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
7. Information We Collect
7.1 Ownership
All content on the Site, including but not limited to text, graphics, images, logos, trademarks, trade names, data compilations, clinical photography, scientific data, page layout, and underlying code (collectively, "Content"), is the property of SFA Therapeutics or its licensors and is protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property and proprietary rights laws.
"SFA Therapeutics," "SFA-002," "SFA-001," "SFA-009," and related names, logos, and designs are trademarks or service marks of SFA Therapeutics, Inc. You may not use any of these marks without our prior written consent.
7.2 Limited License
Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to access and use the Site for your personal, non-commercial, informational purposes. This license does not include the right to:
- Modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any Content.
- Use any data mining, robots, or similar data gathering or extraction methods on the Site.
- Use the Site or Content for any commercial purpose without our prior written consent.
- Frame or mirror any portion of the Site without our prior written authorization.
7.3 Clinical Photography
Clinical photographs displayed on the Site are published with patient consent and are the exclusive property of SFA Therapeutics. Reproduction, distribution, or use of clinical photography without the express written permission of SFA Therapeutics is strictly prohibited.
8. User Conduct
By using the Site, you agree that you will not:
- Use the Site in any manner that could disable, overburden, damage, or impair the Site or interfere with any other party's use of the Site.
- Use any automated means, including robots, crawlers, or scrapers, to access the Site for any purpose without our express written permission.
- Attempt to gain unauthorized access to any portion of the Site, other accounts, computer systems, or networks connected to the Site.
- Use the Site for any purpose that is unlawful, fraudulent, or prohibited by these Terms.
- Introduce any viruses, trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
- Collect or harvest any personally identifiable information from the Site.
- Impersonate or attempt to impersonate the Company, a Company employee, another user, or any other person or entity.t
9. Third-Party Links
The Site may contain links to third-party websites or resources, including but not limited to ClinicalTrials.gov. These links are provided for convenience only and do not constitute an endorsement, sponsorship, or recommendation by SFA Therapeutics. We have no control over, and assume no responsibility for, the content, privacy policies, or practices of any third-party websites. You access third-party websites at your own risk.
10. Disclaimer of Warranties
THE SITE AND ALL CONTENT ARE PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, SFA THERAPEUTICS DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:
- IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
- WARRANTIES THAT THE SITE WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.
- WARRANTIES REGARDING THE ACCURACY, COMPLETENESS, RELIABILITY, TIMELINESS, OR SUITABILITY OF ANY CONTENT ON THE SITE.
SFA THERAPEUTICS DOES NOT WARRANT THAT THE RESULTS OF CLINICAL TRIALS OR INVESTIGATIONAL THERAPIES DESCRIBED ON THE SITE WILL BE REPLICATED IN FUTURE STUDIES OR THAT ANY INVESTIGATIONAL THERAPY WILL RECEIVE REGULATORY APPROVAL.
11. Limitation of Liability
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL SFA THERAPEUTICS, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATED TO:
- YOUR ACCESS TO, USE OF, OR INABILITY TO ACCESS OR USE THE SITE.
- ANY CONTENT OR INFORMATION OBTAINED FROM THE SITE.
- ANY CONDUCT OR CONTENT OF ANY THIRD PARTY ON OR CONNECTED TO THE SITE.
- UNAUTHORIZED ACCESS, USE, OR ALTERATION OF YOUR TRANSMISSIONS OR DATA.
- ANY RELIANCE ON CLINICAL DATA, STUDY RESULTS, OR SCIENTIFIC INFORMATION PRESENTED ON THE SITE.
THIS LIMITATION APPLIES WHETHER THE CLAIM IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, EVEN IF SFA THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OUR LIABILITY SHALL BE LIMITED TO THE MAXIMUM EXTENT PERMITTED BY LAW.
12. Indemnification
You agree to indemnify, defend, and hold harmless SFA Therapeutics, its officers, directors, employees, agents, affiliates, and licensors from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) your use of the Site; (b) your violation of these Terms; or (c) your violation of any rights of a third party.
13. Governing Law and Dispute Resolution
13.1 Governing Law
These Terms and any disputes arising out of or relating to these Terms or the Site shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law principles.
13.2 Jurisdiction
You agree that any legal action or proceeding arising out of or relating to these Terms or the Site shall be brought exclusively in the federal or state courts located in the State of Delaware, and you hereby consent to the personal jurisdiction and venue of such courts.
13.3 Waiver of Jury Trial
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE ARISING OUT OF OR RELATING TO THESE TERMS OR THE SITE.
14. Modifications to These Terms
SFA Therapeutics reserves the right to modify or replace these Terms at any time in its sole discretion. When we make material changes, we will update the "Last Updated" date at the top of this page. Your continued use of the Site after the posting of revised Terms constitutes your acceptance of such changes.
We encourage you to review these Terms periodically.
15. Modifications to the Site
SFA Therapeutics reserves the right to modify, suspend, or discontinue the Site, or any portion thereof, at any time without notice or liability. We shall not be liable to you or any third party for any modification, suspension, or discontinuation of the Site.
16. Severability
If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such invalidity, illegality, or unenforceability shall not affect the remaining provisions of these Terms, which shall remain in full force and effect.
17. Waiver
The failure of SFA Therapeutics to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. Any waiver of any provision of these Terms will be effective only if in writing and signed by SFA Therapeutics.
18. Entire Agreement
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and SFA Therapeutics regarding your use of the Site and supersede all prior and contemporaneous agreements, communications, and proposals, whether oral or written, between you and SFA Therapeutics regarding the Site.
19. Contact Us
If you have any questions about these Terms, please contact us at:
James Kirwin, Data Protection Officer SFA Therapeutics, Inc. 610 Old York Road, Suite 400, Jenkintown, PA 19046 Email: jameskirwin@sfatherapeutics.com
© 2026 SFA Therapeutics, Inc. All rights reserved.
Resetting the immune system © 2026 SFA Therapeutics, Inc.
SFA-002 and all SFA Therapeutics pipeline candidates are investigational therapies and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these therapies have not been established. The information on this website is intended for informational purposes only and should not be construed as medical advice or an offer to participate in a clinical trial. ClinicalTrials.gov Identifier: [pending registration].